... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Neuroendocrine tumors (NETs) Gender differences Genetic profiling Biomarker discovery Liquid biopsy Personalized PRRT Somatostatin analogs Targeted therapy...

... tumors Molecular heterogeneity Metastasis Targeted therapy Genetics Neuroendocrine neoplasms (NENs) are a group of rare tumors that have extensive heterogeneity in terms of histologic origins, degree of differentiation, tumor grades, and presence or absence of functional symptoms [ 1...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Neuroendocrine tumors Signaling MDM2 p53 FOXM1 Targeted therapy Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) are a rare family of heterogeneous...

...Adrian Lee; David L. Chan; Matthew H. Wong; Bob T. Li; Sumit Lumba; Stephen J. Clarke; Jaswinder Samra; Nick Pavlakis Background: Targeted therapies [interferon (IFN), vascular endothelial growth factor (VEGF) inhibitors, and somatostatin analogs (SSA)] have become an integral part...

... progression was associated with changes in gene expression including downregulation of MIR133A . Candidate genes for targeted therapy included ERBB2/HER2, DAD1, PRKCA, RYBP, CASP1, CASP4, CASP5 , VMAT1, RET, APLP1, OR51E1, GPR112, SPOCK1, RUNX1, and MIR133A. Conclusion: Profiling of ileal carcinoids has...